Uromigos-ASCO 2023-Bladder Cancer
Advertisement
Episode 242: ASCO 2023 - The THOR Study: Erdafitinib vs Chemotherapy in Bladder Cancer
The UromigosThe Uromigos | July 17, 2023
Yohann Loriot, MD, PhD, discusses the practice-changing THOR study data on the benefit of erdafitinib for advanced UC.
Listen Now
Episode 246: ASCO 2023 - EV Pembrolizumab and Erdafitinib Cetrelimab in First-line UC
The UromigosThe Uromigos | July 10, 2023
Shilpa Gupta, MD discusses two oral abstracts from ASCO 2023 on the CONTACT-03 trial and the EV-103 trial.
Listen Now
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy